Huangjing Yangji Formula Combined With Resistance Training for Sarcopenia

NCT07321535 · tracked via the Priya Life Science China tracker

Sponsor

Wangjing Hospital, China Academy of Chinese Medical Sciences

Phase

Not applicable

Started

2026-01-15

Last updated

2026-01-07

Condition(s) studied

Sarcopenia

Investigational drug(s) / intervention(s)

Huangjing Yangji Formula GranulesPlacebo Granules for Huangjing Yangji FormulaStandardized Elastic Band Resistance Training Program

Huangjing Yangji Formula Granules: Investigational herbal granule formulation. Each daily dose contains: Polygonati rhizoma (Huangjing) 15g, Codonopsis radix (Dangshen) 10g, Rehmanniae radix praeparata (Shudi) 9g, Angelica sinensis radix (Danggui) 6g, Cistanches herba (Roucongrong) 9g, Lycii fructus (Gouqi) 12g, Poria (Fuling) 9g, and Crataegi fructus (Shanzha) 6g. Administered orally as granules dissolved in water, twice daily (30 minutes after meals), for a period of 3 months.

Placebo Granules for Huangjing Yangji Formula: Matched placebo granules. This preparation is specifically designed to be indistinguishable from the active "Huangjing Yangji Formula Granules" in terms of appearance, color, odor, packaging, and solubility. It contains no pharmacologically active herbal components. Administered orally in the same manner (twice daily, 30 minutes after meals) for 3 months.

Standardized Elastic Band Resistance Training Program: A structured, progressive resistance training program using elastic bands. Participants train 3 times per week for 3 months. Each 60-minute session includes warm-up, 10 core strength exercises (e.g., standing row, leg extension, bridge), and cool-down. Intensity is progressively increased from low (approximately 40-60% of 1-RM) to medium-high (approximately 60-80% of 1-RM) resistance. Sessions are supervised once weekly, with twice-weekly home-based sessions.

Study summary

The goal of this clinical trial is to learn if a traditional Chinese medicine formula called "Huangjing Yangji Formula," combined with elastic band resistance training, works better than exercise alone to improve physical function and muscle strength in older adults with sarcopenia (age-related muscle loss). The main questions it aims to answer are:

Does the combined treatment improve participants' overall physical performance scores more than exercise with a placebo?

Does it lead to better outcomes in walking speed, balance, muscle strength, body composition, nutrition, mood, sleep, and overall quality of life?

Researchers will compare two groups. One group will take the real Huangjing Yangji Formula granules and do the standardized elastic band resistance training. The other group will take placebo granules (a look-alike mixture with no active medicine) and do the same training.

Participants will:

Take the assigned granules twice daily for 3 months.

Complete a standardized elastic band exercise program 3 times per week for 3 months (with both group and home sessions).

Attend three assessment visits (at the start, after 3 months, and 1 month after treatment) for tests and questionnaires.

Provide blood samples at the start and after 3 months for routine safety tests and special muscle health markers.

Eligibility

Sex

ALL

Min age

50 Years

Max age

75 Years

Healthy volunteers

Inclusion Criteria: * Meets the diagnostic criteria for sarcopenia according to the Asian Working Group for Sarcopenia (AWGS) 2025 consensus, defined as the co-presence of: Low Muscle Mass: Appendicular skeletal muscle index (ASMI) measured by multi-frequency bioelectrical impedance analysis (BIA) below the following thresholds: Ages 50-64: \<7.6 kg/m² for men, \<5.7 kg/m² for women. Ages ≥65: \<7.0 kg/m² for men, \<5.7 kg/m² for women. Low Muscle Strength: Handgrip strength below the following thresholds: Ages 50-64: \<34 kg for men, \<20 kg for women. Ages ≥65: \<28 kg for men, \<18 kg for women. * Meets the Traditional Chinese Medicine (TCM) pattern diagnosis criteria for Spleen-Kidney Deficiency Syndrome, characterized by: Primary Symptoms: Muscle wasting, general fatigue, soreness and weakness of the lower back and knees. Secondary Symptoms: Poor appetite, abdominal distension, loose or chronic diarrhea, dizziness, poor memory. Tongue presentation: pale and swollen tongue with tooth marks, white and glossy coating. Pulse: deep, thin, and weak. * Aged between 50 and 75 years. * Willing and able to provide written informed consent personally or via a legal guardian. Exclusion Criteria: * Secondary sarcopenia due to specific diseases (e.g., active malignancy, hyperthyroidism, severe hepatic or renal dysfunction). * Presence of severe or uncontrolled cardiovascular disease, consumptive diseases (e.g., cancer), active infections, or severe osteoporosis. * Diagnosis of Alzheimer's disease, psychiatric disorders, or other cognitive/mental impairments that would hinder cooperation with the trial procedures. * Inability to perform activities of daily living or walk independently; or presence of motor dysfunction due to joint deformities, prolonged bed rest, fractures, or other reasons that would preclude safe participation in resistance training. * Known contraindications to the ingredients of the investigational herbal formula or allergy to the materials of the elastic bands. * Use of medications known to affect muscle metabolism (e.g., corticosteroids, muscle relaxants) within the past 3 months. * Participation in any other interventional clinical trial within the past 3 months.

Primary outcome measure(s)

Short Physical Performance Battery (SPPB) Score — Baseline, 3 months, and 4 months (1-month follow-up).
The SPPB is a composite score ranging from 0 to 12 that assesses lower extremity physical function. It combines three tests: standing balance, 4-meter walking speed, and time to complete five chair stands. Scores are interpreted as: 0-3 (severe limitation), 4-6 (mild limitation), 7-9 (normal function), and 10-12 (excellent function). A higher score indicates better physical performance.

Trial sites (3)

Facility	City	Region
Wangjing Hospital, China Academy of Chinese Medical Sciences	Beijing	Beijing Municipality
The First Affiliated Hospital of Hunan University of Chinese Medicine	Changsha	Hunan
The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine	Tianjin	Tianjin Municipality

More Wangjing Hospital, China Academy of Chinese Medical Sciences trials in China

Osteoporotic Vertebral Compression Fracture Cohort Study Starting soon

A Multicenter Registry-Based Study Across the Spectrum of Degenerative Cervical Myelopathy Starting soon

Other trials for the same condition

Clinical Study of TJ0113 Capsule in the Treatment of Patients With Sarcopenia Recruiting

Silkworm Pupa Powder Improves Dementia. Recruiting

A Study of Silkworm Pupa Powder Intervention in the Nutritional Status of Patients With Alzheimer's Disease. Recruiting

Effects of Shanyu Pill in Older Adults With Sarcopenia Active, not recruiting

Silkworm Pupa Powder Improves Alzheimer's Disease Starting soon

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07321535 on ClinicalTrials.gov ↗ ← All trials in China